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Interaction of the human complement system with humoral and cellular immunity 
was first  suggested by the observation that lymphocyte populations are separable on 
the basis of surface receptors for C3  (1).  Subsequent  reports indicated that  isolated 
C3b either activates (2)  or fails  to activate (3)  murine B lymphocytes. Additionally, 
C3c,  C3d,  and  C3a  have  been  implicated  as  regulators of the  blastogenic  (4)  and 
antibody responses  (5)  of lymphocytes to antigen.  In vivo complement activation in 
lymph nodes inhibits  lymphocyte emigration  for 24 h  (6).  Further  studies  indicate 
that  depletion of circulating C3 with cobra venom factor, after priming,  abrogates 
the development of B cell  memory (7)  as well as the cyclical antibody response (8). 
The use of antisera to purified complement components has supported a  role for C4 
in human (9) but not guinea pig models (10) of cellular immunity. 
We  have  recently  demonstrated  the  existence  of specific  receptors  on  murine 
macrophages for purified human C5a anaphylatoxin, a  low molecular weight glyco- 
peptide  released  from C5  during complement  activation.  These  receptors  have  an 
apparent Kd of~2 nM. In contrast, murine lymphoid cells are devoid of such receptors 
(11). Binding of C5a to macrophages results in augmentation of the primary humoral 
immune response (12).  Immunopotentiation by C5a not only involves C5a receptor- 
bearing  Ia-  accessory cells,  but  Ia  +  antigen-presenting  cells  as  well.  The  present 
studies  demonstrate  that  C5a induces  macrophages and  a  macrophage cell  line  to 
secrete interleukin  1 (IL-1) but not IL-2 into the culture supernatant. Moreover, these 
supernatants augment the primary humoral response in a manner analogous to native 
C5a. 
Materials and Methods 
Mice.  BALB/c and C3H/St male mice, 5-12 wk of age (from Scripps Clinic and Research 
Foundation)  and  CBA/CaJ  and  B6D2Fa male  mice,  8  12  wk  of age  (from  The Jackson 
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Laboratory, Bar Harbor, ME) were maintained on Wayne Lab-Blox F6 pellets and chlorinated 
water (pH 3.0). 
Cell Lines.  The cell lines P388  and  P388DI were obtained through the Cell Distribution 
Center,  Salk  Institute  for  Biological Studies,  La Jolla,  CA.  P388  and  P388Dt  cells  were 
maintained as described (11). CTLL cells were kindly provided by Dr. Amnon Ahman, Medical 
Biology Institute, La Jolla, CA. 
Preparation of Human C5a.  Human C5a was isolated and quantitated as described previously 
(11). When assayed for endotoxin activity by the limulus lysate test, C5a was found to be at the 
lower limit of detection, containing less than or equal the amount of endotoxin in the culture 
medium itself. 
Lymphocyte Cultures.  The  serum-containing medium  used  in  these experiments has  been 
described previously (12).  Spleen cell suspensions were prepared in accordance with published 
procedures ~13). For evaluation of the primary humoral immune response to sheep erythrocytes 
(SRBC),  10  murine spleen cells were cultured in  1.0 ml of 5% heat-inactivated (HI) fetal calf 
serum  (FCS)  containing medium  for 4  d  in  the  presence or absence of SRBC.  Cells were 
incubated  in  culture  trays  (3008,  Falcon  Labware, Oxnard,  CA)  at  37°C  in  a  humidified 
atmosphere of 10% CO2 in air using tissue culture boxes rocked at 7 cpm. Cultures were fed 
daily with 50 #1 of nutritional cocktail (13). 
Pulse Treatment of Cells.  P388 cells, P388D1  cells, and splenic adherent cells were irradiated 
with 2,500 rad from a Gammaceil 40 small animal irradiator (Atomic Energy of Canada, Ltd., 
Ottawa). Splenic adherent cells (SAC) were the cells remaining on plastic petri dishes after a 
1 h  incubation of spleen cells at 4  X  106/ml at 37°C and after three vigorous washes. These 
cells were exposed to  100  ng/ml  C5a for  1 h, washed extensively, and cultured for 96 h  in 
serum-free lymphocyte culture medium  with  1 #M  indomethacin.  Cell lines were similarly 
pulsed with C5a and cultured at 2 ×  106/ml for 96 h in lymphocyte culture medium containing 
I% FCS and  1 #M indomethacin unless otherwise indicated. 
Lymphokine Assays.  IL- 1 content was assayed by the thymocyte mitogenesis and costimulator 
assays (14,  15). Briefly, thymocytes from C3H/St  mice, 5-7 wk of age, were cultured at 5 × 
5  10/ml. Supernatants were used at a dilution of 1:4, and concanavalin (Con A) A at 3 #g/ml. 
After 66 h, cultures were pulsed with 1 #Ci [aH]thymidine ([aH]TdR) for 6 h. IL-2 content was 
assessed by culturing the IL-2-dependent line CTLL, at 5 ×  104/ml, with various dilutions of 
supernatant (16). Cultures were pulsed with 1 #Ci [3H]TdR for the final 24 h of the 2-d culture 
period. 
Assayed of  Plaque-forming Cells (PFC).  PFC secreting antibodies against SRBC were evaluated 
after 4 d ofcuhure using a modification (12) of the hemolytic plaque assay of  Jerne and Nordin. 
Results 
Enhancement of the Prima~y Humoral Immune Response to SRBC by Supernatants from  C5a- 
pulsed P388D1 Cells or SAC.  The ability of C5a and C5a-pulsed cells to potentiate the 
primary humoral immune response has been reported previously (12). The pertinent 
findings of those studies are summarized in Table I. Observation that pulse exposure 
of C5a receptor-bearing cells to C5a enhanced humoral immunity in vitro suggested 
that immunopotentiation might be mediated by secretion of a  lymphokine. 
TABLE  I 
Effect of Anaphylatoxins and C5a-pulsed Cells on the Prima~y Humoral 
Immune Response 
Additive  Effect  on primary SRBC 
response 
C5a  Enhanced 
C5ad,~ .~  Enhanced 
C3a  No effect 
C5a-pulsed peritoneal cells  Enhanced 
C5a-pulsed lymphocytes  No effect 
C5a-pulsed P388Dt cells  Enhanced 914  GOODMAN ET AL.  BRIEF DEFINITIVE  REPORT 
Supernatant  Direct Anti SRBC PFC (~ l O-ZttCulture 
O  5  10  15  20 
-  IM//////.'//H////////ZM//////H.~ 
P388 L//////.'..'/..////////////~  SRBC 
CSa P388 L.////..../////..///////....J  -  S.A.C.  1 
[/IIIII/IIIIIIIItlIIIItlIIIIIIIIIIIIIIIIIA~  SRBC  S.A.C 
/  -  C5a-S.A.C. 
P38BD, ~V///""/HHH/MMMMH/H//MMH////"'~  SRBC  C5a-S.A.C. 
C  5a P388  0, ~#/////////////M/z..~--~ 
Antigen  Supernatanl  Direct  Anti-SRBC  PFC ( × 104)tCulture 






FIe.  1.  (Left) Enhancement of the primary humoral immune reponse by supernatants from C5a- 
pulsed P388D1 and P388 cells. 107 viable spleen cells were cultured in 1.0 ml 5% FCS-containing 
medium for 4 d in the presence or absence of SRBC. Results are the mean of the difference of 
triplicate experimental and control (---152 + 22 PFC) cultures + SE. 
FIG. 2.  (Right) Enhancement of the primary humoral immune response by supernatants from 
C5a-pulsed SAC. l0  T  viable spleen cells were cultured in 1.0 ml 5% FClS-containing  medium for 4 
d in the presence or absence of SRBC. Results are presented as the arithmetic mean of triplicate 
cultures. 
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P3BB 
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FxG.  3.  IL-1  induction by C5a. Thymocytes from C3H/St mice, 5-7 wk of age, were cultured at 
5 X 105/ml  of medium containing 10% HI-FCS and 50/~M 2-mercaptoethanol. Supernatants were 
assayed at a  1:4 dilution, and Con A was added at 3 /~g/ml. Cultures were pulsed with  ! /LCi 
[3H]TdR for the final 6 h of the 3-d incubation period. Results are presented as the arithmetic mean 
of five replicate cultures + S.E. 
To test this hypothesis, culture supernatants were generated from C5a-pulsed cells 
as detailed in Materials and Methods.  Supernatants from the macrophage cell line 
P388, which does not bear C5a receptors, failed to enhance the response to antigen 
regardless of whether or not the cells had been exposed to C5a  (Fig.  1). In contrast, 
supernatants from C5a receptor-bearing P388D1  cells pulsed with C5a significantly 
augmented the  response  to  SRBC.  Moreover,  in  parallel  experiments  with  SAC, 
similar enhancement was observed (Fig. 2). The absence of increased PFC in control 
cultures  (without  antigen)  clearly demonstrates that  SAC  supernatants, generated 
either  with  or  without  prior  incubation with  C5a,  do  not  of  themselves  induce 
polyclonal immunoglobulin  secretion. 
Cellular Specificity of lL-1 Induction by C5a.  Supernatants from CSa-pulsed cells were 
examined for content of the macrophage-derived lymphokine, IL- 1. Two assays were 
used for this purpose: (a)  enhancement of the Con A  response of thymocytes, and (b) 
the mitogenic response of thymocytes to supernatant. Supernatants from  P388 cells 
contained no IL-1 by either assay  (Fig. 3).  Culture supernatants from P388D1 cells, 
however, contained IL-1 as determined by both assays. This activity was even more 
pronounced when production of prostaglandins (which inhibit lymphocyte activation) 
was inhibited by 1/~M indomethacin. GOODMAN  ET  AL.  BRIEF  DEFINITIVE  REPORT  915 
TABLE II 
Examination of Culture Supernatants  for IL-2 Content 
Supernatant 
Cell of origin  Pulsed with: 
IL-2 content ([aH]TdR 
uptake/10  a CTLL)§ 
None  --  740 ±  65 
P388Dl*  --  925 ±  20 
P388D1  C5a  910 ±  70 
SACS  --  735 ±  35 
SAC  C5a  775 ±  50 
Rat spleen  Con A  5,500 ±  120 
* 2 X  10  e irradiated P388D1 cells were pulsed with or without C5a for 1 h and cultured 
for4 d. 
$ Residual adherent cells from 5 x  10  e input CBA/CaJ spleen  cells were irradiated and 
cultured for 4 d in serum-free medium with or without C5a. 
§ 104 viable CTLL cells were cultured with a  1:8 dilution of the supernatant indicated. 
Cultures were pulsed with 1/~Ci [aH]TdR between 24 and 48 h. Results are expressed 
as the arithmatic mean of five replicate cultures ±  SE, in cpm/103 CTLL to conform 
with the prevalent mode. 
Examination of Culture Supernatants for IL-2 Content.  Supernatants generated by either 
P388Da cells or splenic adherent cells in the presence or absence of C5a were tested 
for IL-2 content by their ability to promote proliferation of an IL-2-dependent. cell 
line, CTLL (16). Neither P388D1 cells nor SAC were induced to secrete IL-2 by C5a 
(Table II). Con A supernatants from rat spleen cells, used as a source of IL-2, served 
as a positive control. 
Discussion 
Human C5a anaphylatoxin binds to specific receptors found predominantly on Ia- 
murine macrophages (11). Its binding induces these cells to secrete an active principle 
that  mediates  enhancement  of the  primary  humoral  response  to  SRBC.  These 
supernatants  are  unable  to  increase  the  number  of spontaneous  PFC  to  SRBC, 
indicating that  immunoenhancement is antigen dependent and is not mediated by 
nonspecific polyclonal activation of B cells.  Our current investigations clearly dem- 
onstrate that IL-1, but not IL-2, is selectively elaborated by these cells after a  brief 
exposure to nanomolar concentrations of human C5a. 
Identification of IL-1 in the supernatants of C5a-pulsed macrophages was accom- 
plished  by  two  different  assays.  The  first,  the  thymocyte costimulator assay  (15), 
detects both IL-1 and IL-2 activity. A second assay, involving induction of thymocyte 
mitogenesis (14), is selectively responsive to IL-1. The observation that supernatants 
from C5a-stimulated P388DI cells enhanced cellular responses in both assays impli- 
cates  IL-1  as  the  putative  mediator  released  from  these  cells.  Moreover,  when 
supernatants from C5a-pulsed P388D1 and SAC were examined for IL-2 content by 
measuring proliferation of an IL-2-dependent cell line (CTLL), no IL-2 activity was 
demonstrable. Taken together, these results demonstrate that C5a promotes secretion 
of IL-1, but not IL-2, from responsive cells. 
Several  lines  of evidence  indicate  that  binding  of C5a  to  specific  macrophage 
receptors is the initiating event for elaboration of IL-1 by these cells. First, only cells 
that bear C5a receptors can secrete IL-1 in response to CSa stimulation. Cells that are 
devoid of C5a receptors consistently fail to produce this lymphokine after exposure to 
C5a. Furthermore, the absence of IL-l-like activity in the supernatants of C5a-pulsed 916  GOODMAN ET AL.  BRIEF  DEFINITIVE REPORT 
P388  cells militates  against  nonspecific carryover of cell-associated C5a  as a  trivial 
mechanism of augmentation.  This interpretation  is supported further by our obser- 
vation that cell-bound C5a is rapidly degraded to biologically inactive amino acids 
and/or low molecular weight peptides  (11).  Finally, the inability of C5a to bind to 
murine lymphoid cells (11) makes it unlikely that any intact C5a that might dissociate 
from the  macrophage receptor could  directly account  for the  immunopotentiation 
observed. 
Whereas the mechanism by which IL-1 enhances humoral immunity is controver- 
sial, the observation that humoral responses are augmented by IL- 1 is well established 
(17). The two proposed target cells for IL-1 are the T  cell, which may in turn produce 
IL-2 (18), and the B cell  (19).  Although  investigation of the mode of action of IL-1 
itself is beyond the scope of the current investigations, the data are compatible with 
either thesis. 
Summary 
The  mechanism  by  which  human  C5a  anaphylatoxin  augments  the  primary 
humoral  response of routine  splenocytes to  antigen  has  been  investigated.  Culture 
supernatants were generated from splenic adherent cells or macrophage cell lines after 
exposure to a brief pulse of human C5a. Supernatants from the macrophage-like cell 
line  P388DI,  which  bears surface  receptors  for C5a,  enhance  the  PFC  response  to 
antigen,  whereas  those  from the closely related  cell  line  P388,  which  lacks surface 
receptors  for C5a,  fail  to  cause enhancement.  Supernatants  from splenic  adherent 
cells, which  also bear C5a receptors, similarly augment  the SRBC  response.  Active 
supernatants,  but  not  those devoid of activity, were shown to contain  interleukin  1 
(IL-1) activity by both the thymocyte mitogenesis and thymocyte costimulator assays. 
None of the supernatants contained IL-2 activity. These observations suggest that the 
recently  described  role  of  human  C5a  as  an  immunopotentiating  modulator  is 
mediated by its ability to induce production of IL- 1 upon binding to specific receptors 
at the macrophage cell surface. 
The authors thank Mrs.  Terry Else for superb technical assistance,  Dr. Amnon Altman for 
providing us with the CTLL cell line, and Mrs. Alice Bruce Kay and Mrs. Barbara Marchand 
for excellent secretarial work. 
Received  for publication 19 May 1982 and in revised  form 6July 1982. 
References 
1.  Parish,  C.  R.,  and J. A.  Hayward.  1974. The lymphocyte surface II. Separation  of Fc 
receptor, C'3 receptor and surface immunoglobulin-bearing lymphocytes. Proc. R. Soc. Lond. 
B Biol. Sci. 187:65. 
2.  Hartmann,  K.-U., and  V.  A.  Bokisch.  1975. Stimulation  of murine  B lymphocytes by 
isolated C3b.J. Exp.  Med. 142"600. 
3.  Koopman, W. J., A. L. Sandberg, S. M. Wahl, and W. E. Mergenhagen. 1976. Interaction 
of soluble C3 fragments with guinea pig lymphocytes. Comparison of effects of C3a, C3b, 
C3c, and C3d on lymphokine production and lymphocyte proliferation..]. Immunol. 117;334. 
4.  Schenkein,  H. A., and R. J. Geneo.  1979. Inhibition of lymphocyte blastogenesis  by C3c 
and C3d.J. Immunol. 122;1126. 
5.  Morgan, E. L., W. O. Weigle, and T. E. Hugli. Anaphylatoxin-mediated regulation of the GOODMAN ET AL.  BRIEF DEFINITIVE REPORT  917 
immune response. I. C3a-mediated suppression of human  and murine humoral immune 
responses.,]. Exp. Med. 155:1412. 
6.  McConnell,  I.,  and J.  Hopkins.  1981. Lymphocyte  traffic  through  antigen-stimulated 
lymph  nodes.  I.  Complement  activation  within  lymph  nodes  initiates cell  shutdown. 
Immunology. 42:217. 
7.  Klaus, G. G. B., and J. H. Humphrey.  1977. The generation of memory cells. I. The role 
of C3 in the generation of B memory cells. Immunology. 33:31. 
8.  Romball, C. G., R. J. Ulevitch, and W. O. Weigle. 1980. Role of C3 in the regulation of a 
splenic PFC response in rabbits. J. Immunol. 124:151. 
9.  Ferrone,  S.,  M.  A.  Pellegrino, and  N.  R.  Cooper.  1976. Expression  of C4  on  human 
lymphoid cells and possible involvement in immune recognition phenomena. Science (Wash. 
D. C).  193:53. 
10.  Burger, R., and E. M. Shevach.  1979. Evaluation of the role of C4 in the cellular immune 
response in vitro. J. Immunol. 122:2388. 
11.  Chenoweth, D. E., M. G. Goodman, and W. O. Weigle. 1982. Demonstration of a specific 
receptor for human C5a anaphylatoxin on murine macrophages.J. Exp. Med. 156:68. 
12.  Goodman, M. G., D. E. Chenoweth, and W. O. Weigle. 1982. Potentiation of the primary 
humoral immune response in vitro by C5a anaphylatoxin.J. Immunol. 129:70. 
13.  Mishell, R. I., and R. W. Dutton.  1967. Immunization of dissociated spleen cell cultures in 
normal mice.J. Exp. Med. 126:423. 
14.  Mizel, S. B., J. J. Oppenheim, and D. L. Rosenstreich.  1978. Characterization of lympho- 
cyte-activating factor (LAF) produced by the macrophage cell line, P388Da. J.  Immunol. 
120:1497. 
15.  Mehzer, M.  S., and J. J.  Oppenheim.  1977. Bidirectional amplification of macrophage- 
lymphocyte interactions: enhanced lymphocyte activation factor production by activated 
adherent mouse peritoneal cells. J. Immunol. 118:77. 
16.  Gillis, S., M. M. Ferm, W. Ou, and K. A. Smith. 1978. T cell growth factor: parameters of 
production and a quantitative microassay for activity. J. Immunol. 120:2027. 
17.  Farrar, J. J., and M. L. Hilfiker. 1982. Antigen-nonspecific helper factors in the antibody 
response. Fed. Proc. 41:263. 
18.  Farrar, J. J., and W. J.  Koopman.  1979. Characterization of mitogenic factors and their 
effect on the antibody response in vitro. In Biology of the Lymphokines. S. Cohen, E. Pick, 
and J. J. Oppenheim, editors. Academic Press, Inc., New York. 325-346. 
19.  Wood, D. D., and P. M. Cameron.  1976. Stimulation of the release of a B cell-activating 
factor from human monocytes. Cell. Immunol. 21:133. 